Singer Lizzo reveals she was frustrated being ‘overshadowed’ by her ‘fatness’
American singer Lizzo, has revealed that she was frustrated by being ‘overshadowed’ by her ‘fatness’ in a candid new post reflecting on her weight loss journey. The 37-year-old singer has dramatically slimmed down in recent years after years of embracing her role as the face of the body positivity movement. In her very first Substack post, entitled ‘Why is everybody losing weight […]
UBS sees 60% more upside in Shaily Engineering after a massive 700% rally in two years. Here’s why
UBS has initiated coverage of Shaily Engineering Plastics with a ‘Buy’ rating and a target price of ₹4,000, indicating a 60% upside. The firm highlights Shaily’s patented technology and strong market position for GLP-1 therapies, estimating substantial revenue growth and a 75% EPS CAGR by FY28.
Consider these 3 shares to buy before the Christmas boom
The festive season is an interesting time for the stock market, presenting unique opportunities for shares to buy while other companies take leave. Naturally, retail and e-commerce businesses see the largest boost, while tourism and luxury-related stocks also tend to benefit. Here are three stocks that I think are worth considering as Christmas draws closer. […]
Insulin Doctor: This Is The First Sign Of Dementia! The Shocking Link Between Keto & Brain Decline!
No.1 Keto Doctor DR. ANNETTE BOSWORTH reveals how to reverse insulin resistance, cut belly fat, avoid early dementia, why eating late spikes glucose, and the sardine-only reset for ketosis. Dr Annette Bosworth, commonly known as Dr Boz, is an internal medicine doctor with over 2 decades of experience, who helps reverse medical problems through healthy […]
Shaily Engineering shares up 3%; UBS initiates buy with 60% upside potential
UBS has initiated coverage on Shaily Engineering Plastics with a Buy rating and a target price of Rs 4,000, citing strong growth prospects driven by its patented technology, upcoming GLP-1 generic launch, and improving utilisation across consumer and industrial segments. The brokerage expects robust earnings growth and market share gains supported by high entry barriers […]
Study finds GLP-1 drugs improve strength and reverse aging biology in mice
Researchers showed that GLP-1 receptor agonism counteracts aging across multiple organs in mice, improving strength and reversing molecular aging signatures without meaningful effects on body weight. These benefits depended largely on hypothalamic GLP-1R signaling and closely mirrored the anti-aging patterns produced by rapamycin.
Could Trump do for Branded Expensive Drugs What He Just Did for GLP-1s?
The Trump administration’s new deal lowers prices and expands access to GLP-1 drugs, but experts argue far broader reforms are needed to address high prescription drug costs overall. The post Could Trump do for Branded Expensive Drugs What He Just Did for GLP-1s? appeared first on MedCity News.
Better Than Ozempic? New Oxytocin Combination Could Eliminate Side Effects
In addition to reducing hunger, popular weight-loss drugs also affect reward processing and motivated behaviors. New research is offering a clearer picture of how medications that target the glucagon-like peptide-1 (GLP-1) system influence brain networks involved in nausea, thirst, and reward-driven behaviors. These new results were recently shared at Neuroscience 2025, the annual meeting of […]
Eli Lilly to Launch a GLP-1 Pill to Rival Ozempic, but There’s a Catch
The new drug will target weight loss for people with obesity and type 2 diabetes.
Daily oral GLP-1 pill a promising alternative to injectables for weight loss, clinical trial finds
A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial led by a UTHealth Houston researcher.